Analyze, Deliver, Measure, and Communicate Value Across the Product Lifecycle.
EVERSANA is a Silver Sponsor of the Canadian Agency for Drugs and Technologies in Health (CADTH) in Toronto, Ontario, and EVERSANA experts join industry colleagues to share their insight to more than 1000 attendees involved in the areas of policy-making, program decision-making, health care delivery, and research in the objective assessment and evaluation of health technologies.
FULL-DAY WORKSHOP: April 19, 9am-4pm
“NMA, MAIC, STC, PSM: Understanding the Various Indirect Treatment Comparison Methods and Which Method Should Be Used to Support HTA and Reimbursement Submissions.” Presented by: EVERSANA’s Dr. Chris Cameron, Tim Disher, and Anja Haltner; and Dr. Brian Hutton, Ottawa Hospital Research Institute
SCIENTIFIC POSTER EXHIBITION: April 19, 5-7pm
“Incorporating Data from Adaptive Trial Designs in Network Meta-Analysis (NMA): Methodological Challenges and Opportunities.” Presented by: EVERSANA’s Dr. Chris Cameron and Anja Haltner; and Sandra Iczkovitz, Janssen
PANEL PRESENTATION: April 21, 1-2:15pm
“The Evolution of Health Technology Assessment: How Must Canadian Stakeholders Adapt to the Use of Pharmacoeconomic Analyses for Regulatory Pricing Decisions?” Presented by: EVERSANA’s Dr. Chris Cameron; Beena Kuriakose, Janssen; Dr. Durhane Wong Rieger, Canadian Organization for Rare Disorders (CORD); and Wayne Critchley, Global Public Affairs
Connect with our experts. Learn how our integrated commercial solutions are designed to solve global pricing, access, reimbursement adherence and product delivery challenges for the life science sector.